Jill R Storry1, Frederik Banch Clausen2, Lilian Castilho3, Qing Chen4, Geoff Daniels5, Greg Denomme6, Willy A Flegel7, Christoph Gassner8, Masja de Haas9, Catherine Hyland10, Ji Yanli11, Margaret Keller12, Christine Lomas-Francis13, Nuria Nogues14, Martin L Olsson1,15, Thierry Peyrard16, Ellen van der Schoot17, Yoshihiko Tani18, Nicole Thornton19, Franz Wagner20, Christoph Weinstock21, Silvano Wendel22, Connie Westhoff13, Vered Yahalom23. 1. Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Lund, Sweden. 2. Department of Clinical Immunology, Laboratory of Blood Genetics, Copenhagen University Hospital, Copenhagen, Denmark. 3. University of Campinas/Hemocentro, Campinas, Brazil. 4. Jiangsu Province Blood Center, Nanjing, Jiangsu, China. 5. Bristol Institute for Transfusion Sciences, NHS Blood and Transplant, Bristol, UK. 6. Blood Center of Wisconsin, Milwaukee, WI, USA. 7. Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA. 8. Blutspende Zurich, Zurich, Switzerland. 9. Sanquin Blood Supply Foundation, Amsterdam, The Netherlands. 10. Australian Red Cross Blood Services, Brisbane, QLD, Australia. 11. Institute of Clinical Blood Transfusion Guangzhou Blood Center, Guangzhou, China. 12. American Red Cross Blood Services, Philadelphia, PA, USA. 13. New York Blood Center, New York, NY, USA. 14. Banc de Sang i Teixits, Barcelona, Spain. 15. Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden. 16. Laboratoire d'Excellence GR-Ex, Institut National de la Transfusion Sanguine, Département Centre National de Référence pour les Groupes Sanguin, UMR_S1134 Inserm, Université Paris Diderot, Paris, France. 17. Sanquin Research at CLB, Amsterdam, The Netherlands. 18. Osaka Red Cross Blood Center, Osaka, Japan. 19. International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK. 20. Red Cross Blood Service NSTOB, Springe, Germany. 21. German Red Cross Blood Service, Bade-WurttembergHessen, Ulm, Germany. 22. Blood Bank, Hospital Sirio-Libanes, São Paulo, Brazil. 23. Rabin Medical Center, Petach Tiqva, Israel.
Abstract
BACKGROUND AND OBJECTIVES: The International Society of Blood Transfusion (ISBT) Working Party for Red Cell Immunogenetics and Blood Group Terminology meets in association with the ISBT congress and has met three times since the last report: at the international meetings held in Dubai, United Arab Emirates, September 2016 and Toronto, Canada, June 2018; and at a regional congress in Copenhagen, Denmark, June 2017 for an interim session. METHODS: As in previous meetings, matters pertaining to blood group antigen nomenclature and classification were discussed. New blood group antigens were approved and named according to the serologic and molecular evidence presented. RESULTS AND CONCLUSIONS: Fifteen new blood group antigens were added to eight blood group systems. One antigen was made obsolete based on additional data. Consequently, the current total of blood group antigens recognized by the ISBT is 360, of which 322 are clustered within 36 blood groups systems. The remaining 38 antigens are currently unassigned to a known system. Clinically significant blood group antigens continue to be discovered, through serology/sequencing and/or recombinant or genomic technologies.
BACKGROUND AND OBJECTIVES: The International Society of Blood Transfusion (ISBT) Working Party for Red Cell Immunogenetics and Blood Group Terminology meets in association with the ISBT congress and has met three times since the last report: at the international meetings held in Dubai, United Arab Emirates, September 2016 and Toronto, Canada, June 2018; and at a regional congress in Copenhagen, Denmark, June 2017 for an interim session. METHODS: As in previous meetings, matters pertaining to blood group antigen nomenclature and classification were discussed. New blood group antigens were approved and named according to the serologic and molecular evidence presented. RESULTS AND CONCLUSIONS: Fifteen new blood group antigens were added to eight blood group systems. One antigen was made obsolete based on additional data. Consequently, the current total of blood group antigens recognized by the ISBT is 360, of which 322 are clustered within 36 blood groups systems. The remaining 38 antigens are currently unassigned to a known system. Clinically significant blood group antigens continue to be discovered, through serology/sequencing and/or recombinant or genomic technologies.
Authors: Willy A Flegel; Gregory A Denomme; John T Queenan; Susan T Johnson; Margaret A Keller; Connie M Westhoff; Louis M Katz; Meghan Delaney; Ralph R Vassallo; Clayton D Simon; S Gerald Sandler Journal: Transfusion Date: 2020-03-12 Impact factor: 3.337
Authors: Willy Albert Flegel; Kshitij Srivastava; Tristan Michael Sissung; Barry Ronald Goldspiel; William Douglas Figg Journal: Vox Sang Date: 2020-09-30 Impact factor: 2.996